×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Bear market strikes again: 4D Pharma sinks into administration as creditor calls in loans
Fierce Biotech
4D Pharma has gone into administration after failing to secure a loan to help ride out the “difficult” market conditions.
22 months ago
MediLink and Roche partner on cancer drug development
Pharmaceutical Technology
MediLink Therapeutics has signed a global partnership and licence deal with Roche to develop YL211 for solid tumours.
4 months ago
CJ Bioscience conducts paid-in capital increase of $50 mn
KED Global
South Korea's CJ Bioscience Inc., a pharmaceutical company specializing in intestinal microorganisms called microbiomes, will conduct a...
11 months ago
Firm Advises 4D pharma on Merger with Longevity Acquisition Corporation and Nasdaq ADS Listing
Wilson Sonsini
On March 22, 2021, 4D pharma plc, a Leeds, UK-based pharmaceutical company leading the development of Live Biotherapeutic products (LBPs)—a...
37 months ago
4D Pharma subsidiary sold but UK and Ireland jobs lost
Insider Media Ltd
A Spanish subsidiary of pharmaceutical company 4D Pharma has been acquired out of administration, safeguarding 40 jobs, but 30 employees in...
11 months ago
4D Pharma Begins Phase II COVID-19 Study
Contract Pharma
MRx-4DP0004, an immunomodulatory therapy, has shown potential to down-regulate hyper-inflammatory response while maintaining anti-viral...
48 months ago
4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and ...
Business Wire
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs),...
25 months ago
Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK
KED Global
South Korea's pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve...
13 months ago
4D pharma to initiate Phase II study of MRx-4DP0004 to treat COVID-19
European Pharmaceutical Review
The UK MHRA granted expedited acceptance for the Phase II trial of MRx-4DP0004, a live biotherapy product and targeted immunomodulatory...
48 months ago
Asthma Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - GlaxoSmithKline ...
GlobeNewswire
According to DelveInsight's' estimates, the asthma market in 7MM is expected to show good positive growth, during the forecast period...
13 months ago